Zhuohang Li

No. 1838, North Guangzhou Avenue
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

A serum-clinical composite model for prostate cancer diagnosis: multicenter validation and CRISPR/Cas13a-based detection.

A serum-clinical composite model for prostate cancer diagnosis: multicenter validation and CRISPR/Cas13a-based detection.

Journal: The journal of liquid biopsy
Published: June 22, 2026

Irritable bowel syndrome subtype predicts treatment response and defines distinct mechanistic phenotypes in OAB-IBS comorbidity: a prospective observational study.

Irritable bowel syndrome subtype predicts treatment response and defines distinct mechanistic phenotypes in OAB-IBS comorbidity: a prospective observational study.

Journal: World journal of urology
Published: December 09, 2025

Microbiota-mediated modulation of the tumor microenvironment in urological cancers: crosstalk between gut and intratumoral microbiota.

Microbiota-mediated modulation of the tumor microenvironment in urological cancers: crosstalk between gut and intratumoral microbiota.

Journal: Cellular & molecular biology letters
Published: November 03, 2025

Metabolic-Immune Coupling in Urologic Cancers: Macrophage Reprogramming as a Therapeutic Nexus.

Metabolic-Immune Coupling in Urologic Cancers: Macrophage Reprogramming as a Therapeutic Nexus.

Journal: International journal of biological sciences
Published: October 31, 2025

M2 macrophage related genes predict prognosis and drug response in prostate cancer.

M2 macrophage related genes predict prognosis and drug response in prostate cancer.

Journal: Discover oncology
Published: September 15, 2025

The Role of Estrogen Signaling Pathway and Targeted Therapy Exploration in Urological Tumors.

The Role of Estrogen Signaling Pathway and Targeted Therapy Exploration in Urological Tumors.

Journal: International journal of biological sciences
Published: August 16, 2025

Metabolic Reprogramming in Urological Tumors: New Perspectives from Tumor Metabolic Phenotypes to Therapeutic Targets.

Metabolic Reprogramming in Urological Tumors: New Perspectives from Tumor Metabolic Phenotypes to Therapeutic Targets.

Journal: International journal of biological sciences
Published: August 13, 2025

The effects of antibiotics use during early life and genetic risk on urolithiasis incidence: a large-scale UK biobank cohort study.

The effects of antibiotics use during early life and genetic risk on urolithiasis incidence: a large-scale UK biobank cohort study.

Journal: World journal of urology
Published: August 10, 2025

Efficacy and safety of super-pulse thulium fiber laser compared to holmium: YAG laser for ureteral and renal stones: a multicenter retrospective study.

Efficacy and safety of super-pulse thulium fiber laser compared to holmium: YAG laser for ureteral and renal stones: a multicenter retrospective study.

Journal: Urolithiasis
Published: June 27, 2025

Urinary exosomal FAM153C-RPL19 chimeric RNA as a diagnostic and prognostic biomarker for prostate cancer in Chinese patients.

Urinary exosomal FAM153C-RPL19 chimeric RNA as a diagnostic and prognostic biomarker for prostate cancer in Chinese patients.

Journal: Cancer letters
Published: May 29, 2025

Role of tertiary lymphoid structures in the tumour microenvironment and immunotherapy response of renal cell carcinoma.

Role of tertiary lymphoid structures in the tumour microenvironment and immunotherapy response of renal cell carcinoma.

Journal: Clinical and translational medicine
Published: March 04, 2025

Association of 5α-reductase inhibitor prescription with immunotherapy efficacy in metastatic renal cell carcinoma: a multicenter retrospective analysis.

Association of 5α-reductase inhibitor prescription with immunotherapy efficacy in metastatic renal cell carcinoma: a multicenter retrospective analysis.

Journal: Journal for immunotherapy of cancer
Published: February 11, 2025
Showing 1-12 of 34

Last Updated: 09/26/2026